Mu-delta interactions in vitro and in vivo

The Delta Receptor

Volumn , Issue , 2003, Pages 373-382

  Rothman, Richard B ^a   Xu, Heng ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57349117871     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (25)

1. Hough LB Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 2001; 59(3):415-419.
2. Vaught JL, Takemori AE. A further characterization of the differential effects of leucine enkephalin, methionine enkephalin and their analogs on morphineinduced analgesia. J Pharmacol Exp Ther 1979; 211:280-283.
3. Lee NM, Leybn L, Chang J-K, Loh HH. Opiate and peptide interaction: effect of enkephalins on morphine analgesia. Eur J Pharmacol 1980; 68:181-185.
4. Rothman RB, Holaday JW, Porreca F. Allosteric coupling among opioid receptors: evidence for an opioid receptor complex. In: Herz A, ed. Handbook of Experimental Pharmacology. “Opioids.” Vol. 104. Berlin: Springer-Verlag, 1992:217-237.
5. Cotton R, Giles MG, Miller L, Shaw JS, Tims D. ICI174,864: a highly selective anatgonist for the opioid delta-receptor. Eur J Pharmacol 1984; 97:331-332.
6. Heyman JS, Jiang Q, Rothman RB, Mosberg HI, Porreca F. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists. Eur J Pharmacol 1989; 169:43-52.
7. Porreca F, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI. Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors. J Pharmacol Exp Ther 1992; 263:147-152.
8. Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F. Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol 1996; 36:379-401.
9. Xu H, Partilla JS, de Costa BR, Rice KC, Rothman RB. Differential binding of opioid peptides and other drugs to two subtypes of opioid deltancx binding sites in mouse brain: further evidence for delta receptor heterogeneity. Peptides 1993; 14:893-907.
10. D’Amato R, Holaday JW. Multiple opiate receptors in endotoxic shock:evidence for delta involvement and mu-delta interactions in vivo. Proc Natl Acad Sci USA 1984; 81:2898-2901.
11. Tortella FC, Robles L, Holaday JW. The anticonvulsant effects of DADL are primarily mediated by activation of delta opioid receptors: interaction between delta and mu-receptor antagonists. Life Sci 1985; 37:497-503.
12. Holaday JW, Tortella FC, Maneckjee R, Long JB. In vivo interactions among opiate receptor agonists and antagonists. NIDA Res Monogr 1986; 71:173-188.
13. Schoffelmeer AN, Rice KC, Heijna MH, Hogenboom F, Mulder AH. Fentanyl isothiocyanate reveals the existence of physically associated mu- and delta-opioid receptors mediating inhibition of adenylate cyclase in rat neostriatum. Eur J Pharmacol 1988; 149:179-182.
14. Rothman RB, Westfall TC. Morphine allosterically modulates the binding of 3H-leucine enkephalin to a particulate fraction of rat brain. Mol Pharmacol 1982; 21:538-547.
15. Kim C-H, Rothman RB, Jacobson AE, Mattson MV, Bykov V, Streaty RA, Klee WA, George C, Long JB, Rice KC. Probes for narcotic receptor mediated phenomena. 15. (3S,4S)-(+)-trans-3-methylfentanyl isothiocyanate, a potent site-directed acylating agent for the delta opioid receptors in vitro. JMed Chem 1989; 32:1392-1398.
16. Rothman RB, Mahboubi A, Bykov V, Kim C-H, Jacobson AE, Rice KC. Probing the opioid receptor complex with (+)-trans-SUPERFIT I Evidence that [D-Pen2, D-Pen5]enkephalin interacts with high affinity at the *cx binding site. Peptides 1991; 12:359-364.
17. Rothman RB, Mahboubi A, Bykov V, Kim C-H, de Costa BR, Jacobson AE, Rice KC. Probing the opioid receptor complex with (+)-trans-superfit. II Evidence that A ligands are noncompetitive inhibitors of the ycx opioid peptide binding site. Peptides 1992; 13:1137-1143.
18. Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC, Holaday JW. Beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. J Pharmacol Exp Ther 1988; 247:405-416.
19. Schmidt BL, Tambeli CH, Levine JD, Gear RW Mu/delta cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat. Eur J Neurosci 2002; 15(5):861-868.
20. Chen ZW, Yang K, Wang Y, Han JS The metabolic evidence of synergistic interaction between DAMGO and DPDPE on undifferentiated SH-SY5Y cells. Neuroreport 2001; 12(4):845-849.
21. Martin NA, Prather PL Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells. Mol Pharmacol 2001; 59(4):774-783.
22. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, Devi LA Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J Neurosci 2000; 20(22):RC110.
23. Schoffelmeer AN, Yao Y-H, Simon EJ. Cross-linking of human 125I-betaendorphin to a mu-delta opioid receptor complex in rat striatum. Eur J Pharmacol 1989; 166:357-358.
24. Schoffelmeer AN, Yao YH, Gioannini TL, Hiller JM, Ofri D, Roques BP, Simon EJ. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. J Pharmacol Exp Ther 1990; 253:419-426.
25. Levac BA, O’Dowd BF, George SR Oligomerization of opioid receptors:generation of novel signaling units. Curr Opin Pharmacol 2002; 2(1):76-81.